FDA Leadership Change
A significant appointment has been made with the selection of Makary to lead the FDA, a move praised for his skepticism towards previous COVID policies. He aims to restore trust in the agency while addressing critical issues like harmful chemicals in food and the slow drug approval process. His track record during the pandemic highlights his commitment to a more efficient and transparent regulatory environment.In this clip
From this podcast
The Ben Shapiro Show
Trump Makes His FINAL PICKS
Related Questions